Specifically, SMAD2 and 4 were shown to physically interact with GLI1 along with PCAF in pancreatic cancer cells, and enhance GLI1-dependent BCL2 transcription through PCAF-mediated epigenetic activation [94]. The gene discussed is GLI1; the disease is familial pancreatic carcinoma.